COVID-19 AP TP Vaccine

COVID-19 AP TP Vaccine Uses, Dosage, Side Effects, Food Interaction and all others data.

As of July 2020, Medicine Invention Design, Inc. is sponsoring a small, controlled clinical trial for the COVID-19 AP TP Vaccine for ‘proof of concept.’ The vaccine utilizes granulocyte macrophage-colony stimulating factor (GM-CSF), a cytokine known to enhance vaccine efficacy through prolongation of humoral and cell immunity.

Trade Name	COVID-19 AP TP Vaccine
Generic	COVID-19 Nucleocapsid-GM-CSF Protein Lactated Ringer's Injection
COVID-19 Nucleocapsid-GM-CSF Protein Lactated Ringer's Injection Other Names	AP-TP-V, COVID-19 AP TP Vaccine, COVID-19 Therapeutic Vaccine - Nucleocapsid-GM-CSF Protein Lactated Ringer's Injection
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Innovators Monograph

You find simplified version here COVID-19 AP TP Vaccine